NewslettersIntestinal Cell NewsOrally-Delivered, Cytokine-Engineered Extracellular Vesicles for Targeted Treatment of Inflammatory Bowel DiseaseBy Jamie Kang - September 21, 20230229In a murine model of colitis, Gal-IL10-extracellular vesicles alleviated inflammatory bowel disease symptoms including inflammatory responses and disrupted colonic barriers.[Small]Abstract